Medpace director exercises 36 RSUs into shares
Medpace Holdings director Brian T. Carley exercised restricted stock units into common stock.
Accepted by SEC EDGAR
Learn about SEC filing dates
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
Medpace Holdings director Brian T. Carley exercised restricted stock units into common stock. On March 31, 2026, 36 restricted stock units converted into 36 shares at a stated price of $0.00 per share, bringing his direct common stock holdings to 32,789 shares and leaving 107 restricted stock units outstanding from a prior grant.
Insider Trade Summary
36 shares exercised/converted
Exercise
2 txns
Insider
Carley Brian T
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Restricted Stock Unit | 36 | $0.00 | $0.00 |
| Exercise | Common Stock | 36 | $0.00 | $0.00 |
Holdings After Transaction:
Restricted Stock Unit — 107 contracts (Direct);
Common Stock — 32,789 shares (Direct)
Holdings Before and After:
Restricted Stock Unit, 143 to 107 contracts (Direct);
Common Stock, 32,753 to 32,789 shares (Direct)
Footnotes (2)
- F1. Each restricted stock unit represents a contingent right to receive one share of MEDP common stock.
- F2. On November 28, 2025, the Reporting Person was granted 143 restricted stock units vesting in four approximately equal installments on March 31, 2026, June 30, 2026, September 30, 2026 and December 31, 2026.
Key Figures
RSUs exercised: 36 units
Common shares held after transaction: 32,789 shares
Remaining RSUs: 107 units
+2 more
5 metrics
RSUs exercised
36 units
Converted into 36 Medpace common shares on March 31, 2026
Common shares held after transaction
32,789 shares
Direct Medpace common stock ownership following March 31, 2026 conversion
Remaining RSUs
107 units
Restricted stock units held after 36 units vested and converted
Original RSU grant
143 units
Granted on November 28, 2025, vesting in four installments
Exercise price per share
$0.00/share
Stated price for the 36 Medpace common shares delivered
Key Terms
Restricted Stock Unit, derivative security, contingent right, vesting
4 terms
Restricted Stock Unit financial
"Each restricted stock unit represents a contingent right to receive one share of MEDP common stock."
A restricted stock unit is a promise from a company to give an employee shares of stock after certain conditions are met, like staying with the company for a set amount of time. It’s like earning a bonus that turns into company stock once you’ve proven your commitment, making it a way to motivate and reward employees.
derivative security financial
"Exercise or conversion of derivative security"
A derivative security is a financial contract whose value comes from the price or performance of something else, such as a stock, bond, commodity, or market index. For investors it acts like an insurance policy or a wager: it can be used to protect against losses, lock in prices, or amplify gains and losses, so it can change a portfolio’s risk and potential return without owning the underlying asset directly.
contingent right financial
"represents a contingent right to receive one share of MEDP common stock"
vesting financial
"restricted stock units vesting in four approximately equal installments"
Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did Medpace (MEDP) director Brian T. Carley report?
Brian T. Carley reported exercising restricted stock units into common shares. On March 31, 2026, 36 restricted stock units converted into 36 Medpace common shares, increasing his direct stock ownership while reducing his restricted unit balance from an earlier equity grant.
What restricted stock unit grant underlies Brian T. Carley’s Medpace (MEDP) Form 4?
The Form 4 references a grant of 143 restricted stock units made on November 28, 2025. These units vest in four approximately equal installments on March 31, 2026, June 30, 2026, September 30, 2026 and December 31, 2026, each delivering one Medpace common share per unit.
How many Medpace (MEDP) restricted stock units remain for Brian T. Carley?
Following the March 31, 2026 vesting and conversion of 36 restricted stock units, Brian T. Carley holds 107 restricted stock units. Each unit represents a contingent right to receive one Medpace common share as future vesting installments occur under the original 143-unit grant.
Was Brian T. Carley’s Medpace (MEDP) transaction a market purchase or sale?
The transaction was an exercise and conversion of restricted stock units, not an open-market trade. Code M on the Form 4 indicates derivative exercise, with 36 units converting into 36 Medpace common shares at a stated price of $0.00 per share.
AI-generated analysis. How Rhea-AI works. Not financial advice.
